Aaress Lab Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 16.91%
- Profit Growth 26.68%
- Ebitda 302.89%
- Net Worth 40.56%
- Total Assets 60.60%
About Aaress Lab
Aaress Lab Private Limited (ALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 March 2017 (Seven years and 11 months 8 days old ). Its registered office is in Saharanpur, Uttar Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Rajan Chawla and Sachi Chawla serve as directors at the Company.
Company Details
- Location
Saharanpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304UP2017PTC091356
- Company No.
091356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does Aaress Lab Private Limited offer?
Aaress Lab Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Medicines, Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Aaress Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Chawla  | Director | 16-Mar-2017 | Current |
| Sachi Chawla | Director | 16-Mar-2017 | Current |
Financial Performance of Aaress Lab.
Aaress Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.91% increase. The company also saw a substantial improvement in profitability, with a 26.68% increase in profit. The company's net worth Soared by an impressive increase of 40.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aaress Lab?
In 2023, Aaress Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2022 | Axis Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Aaress Lab?
Unlock and access historical data on people associated with Aaress Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaress Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaress Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.